Related Experiment Videos
The relative role of PAF-acether and icosanoids in septic shock
Abstract:
Endotoxemia and gram negative sepsis remain a clinically important problem since mortality rate is still high in these diseases. Recently, the participation of some new potential mediators in this pathology is beginning to be demonstrated but the results obtained on animal models with specific inhibitors are contradictory. In order to clarify the pathological importance of icosanoids and PAF-acether in the septicemic process, we investigated the effects of indomethacin (IND) a cyclooxygenase inhibitor, NDGA and EP 10045 two lipoxygenase inhibitors, dexamethasone (DXM) a phospholipase A2 inhibitor and BN 52021 a PAF-acether receptor antagonist, on the Salmonella enteritidis-induced endotoxic shock (E.S.) in the rat. Injected subcutaneously 15 min before the test, NDGA, EP 10045 and IND were moderately effective when DXM completely prevented the endotoxin lethality. BN 52021 decreased the death rate in a dose-related manner and exerted at a non-active dose a synergistic effect on IND treatment. Furthermore, given orally 1 hour before endotoxin, it provided a potent protective effect. Our results seem to confirm that PAF-acether exerted alone, or in conjunction with products of the cyclooxygenase pathway, a key role in E.S. when LTs seem to play a role of minor importance.
Insights
Platelet-activating factor-acether (PAF-acether) plays a key role in endotoxic shock, potentially alongside cyclooxygenase products. Lipoxygenase inhibitors had minor effects, while dexamethasone and PAF-acether receptor antagonists offered significant protection.
Area of Science:
- Pharmacology
- Immunology
- Toxicology
Background:
- Sepsis and endotoxemia are significant clinical challenges with high mortality rates.
- The roles of mediators like icosanoids and platelet-activating factor-acether (PAF-acether) in sepsis are not fully understood.
- Previous studies using specific inhibitors in animal models have yielded contradictory results.
Purpose of the Study:
- To clarify the pathological importance of icosanoids and PAF-acether in endotoxic shock.
- To investigate the effects of various inhibitors on Salmonella enteritidis-induced endotoxic shock in rats.
Main Methods:
- Administered indomethacin (cyclooxygenase inhibitor), NDGA and EP 10045 (lipoxygenase inhibitors), dexamethasone (phospholipase A2 inhibitor), and BN 52021 (PAF-acether receptor antagonist) to rats.
- Evaluated the protective effects against Salmonella enteritidis-induced endotoxic shock.
- Assessed dose-dependency and synergistic effects of treatments.
Main Results:
- Dexamethasone completely prevented endotoxin lethality.
- BN 52021 decreased mortality in a dose-related manner and showed synergistic effects with indomethacin.
- Lipoxygenase inhibitors and indomethacin demonstrated moderate effectiveness.
- PAF-acether receptor antagonism provided potent protection when administered orally.
Conclusions:
- PAF-acether, alone or with cyclooxygenase products, plays a crucial role in endotoxic shock.
- Leukotrienes (LTs) appear to have a minor role in this pathology.
- Targeting PAF-acether pathways may be a promising therapeutic strategy for endotoxic shock.